Medikamentös Induzierte Zytopenien auf Immunologischer Basis

  • H. Huber
  • G. Michlmayr
Conference paper
Part of the Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 16)

Zusammenfassung

Verschiedene immunpathologische Phänomene können medikamentös induzierten Zytopenien zu Grunde liegen:
  1. 1.

    Komplexe des Medikaments mit Antikörpern werden an Blutzellen gebunden (9, 21, 36);

     
  2. 2.

    Das Medikament zeigt eine Affinität für Blutzellen, Antikörper gegen diese werden damit auch an Blutkörperchen gebunden (6, 30, 36); oder

     
  3. 3.

    durch Medikamente wird eine echte Autoantikörperbildung gegen Blutzellen ausgelöst (19, 36).

     

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Ackroyd, J.P.: The pathogenesis of thrombocytopenic purpura due to hypersensitivity to Sedormid. Clin. Sci., 7, 249 (1949)PubMedGoogle Scholar
  2. 2.
    Allison, A.C., Denman, A.M., Barnes, R.D.: Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet 2, 135 (1971)PubMedCrossRefGoogle Scholar
  3. 3.
    Aster, R.H.: Thrombocytopenia due to enhanced platelet destruction. In “Hematology” (W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles eds.). New York 1972, p 1131 ffGoogle Scholar
  4. 4.
    Bianco, C., Patrick, R., Nussenzweig, V.: A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J. exp. Med. 132, 702, 1970PubMedCrossRefGoogle Scholar
  5. 5.
    Bock, H.E.: Allergie und Agranulozytose. In “Nebenwirkungen von Arzneimitteln auf Blut und Knochenmark” (R. Jürgens, G.J. Waldenstrom eds.), Schattauer, Stuttgart 1957, p 89 ffGoogle Scholar
  6. 5a.
    Dickler, H.B., Kunkel, H.G.: Interaction of aggregated gamma-globulin with B lymphocytes. J. exp. Med. 136, 191 (1972)PubMedCrossRefGoogle Scholar
  7. 6.
    Fischer, J.T.: Medikamentös bedingte immunhämolytische Anämien. Dtsch. Med. Wschr. 98, 2407 (1973)PubMedCrossRefGoogle Scholar
  8. 7.
    Gralnick, H.R., Mc Ginnis, M., Elton, W., Mc Curdy, P.: Hemolytic anemia associated with cephalotin. J. Amer. Med. Ass. 217, 1193 (1971)CrossRefGoogle Scholar
  9. 8.
    Gralnick, H.R., Wright, L.D., Mc Ginnis, M.H.: Coombs’ positive reactions associated with sodium cephalotin therapy. J. Amer. Med. Ass. 199, 725 (1967)CrossRefGoogle Scholar
  10. 9.
    Hartl, P.W.: Drug induced agranulocytosis. In “Blood disorders due to drugs and other agents”. Exc. Med., Amsterdam 1973, p 147 ffGoogle Scholar
  11. 10.
    Huber, H.: unveröffentlichtGoogle Scholar
  12. 11.
    Huber, H., Douglas, S.D., Fudenberg, H.H.: The IgG receptor: an immunologic marker for the characterization of mononuclear cells. Immunology 17, 7 (1969)PubMedGoogle Scholar
  13. 12.
    Huber, H., Fudenberg, H.H.: Receptor sites of human monocytes for IgG. Int. Arch. Allergy 34, 18 (1968)PubMedCrossRefGoogle Scholar
  14. 13.
    Huber, H., Holm, G.: Surface receptors of mononuclear phagocytes: effect of immune complexes on in vitro function of human monocytes. In “Mononuclear phagocytes” Vol., 2 ( R. van Furth ed.), Blackwell, Oxford 1974 (in Druck)Google Scholar
  15. 14.
    Huber, H., Polley, M.H., Linscott, W.D., Fudenberg, H.H., Müller-Eberhard, H.J.: Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. Science 162, 1281 (1968)PubMedCrossRefGoogle Scholar
  16. 15.
    Lay, H.W., Nussenzweig, V.: Receptors for complement on leucocytes. J. exp. Med. 128, 991 (1968)PubMedCrossRefGoogle Scholar
  17. 16.
    Levine, B.B., Fellner, M.J., Levjtska, V.: Benzyl penicilloyl specific serum antibodies to penicillin in man. I. Development of a sensitive hemagglutination assay method and haptenic specifities of antibodies. J. Immun. 95, 707 (1966)Google Scholar
  18. 17.
    Levine, B.B., Fellner, M.J., Levjtska, V., Franklin, E.C., Alisberg, N.: Benzyl penicilloyl specific serum antibodies to penicillin in man. II. Sensitivity of the hemagglutination assay method, molecular classes of the antibodies detected, and antibody titers of randomly selected patients. J. Immun. 95, 719 (1966)Google Scholar
  19. 18.
    Lobuglio, A.F., Cotran, R.S., Jandl, J.H.: Red cells coated with immunoglobulin G. Bindig and sphering by mononuclear cells in man. Science 162, 128 (1967)Google Scholar
  20. 19.
    Lobuglio, A,F. und Jandl, J.H.: The nature of the alphamethyldopa red cell antibody. New Engl. J. Med. 276, 658 (1967)PubMedCrossRefGoogle Scholar
  21. 20.
    Michlmayr, G., Huber, H.: Receptor sites for complement on certain peripheral blood lymphocytes. J. Immn. 105, 670 (1970)Google Scholar
  22. 21.
    Miescher, P.A.: Drug-induced thrombocytopenia. Sem. Hemat. 10, 311 (1973)Google Scholar
  23. 22.
    Moeschlin, S., Wagner, K.: Agranulocytosis due to the occurence of leukocyte agglutinins (Pyramidon and coldagglutinins). Acta haemat. 8, 29 (1952)PubMedCrossRefGoogle Scholar
  24. 23.
    Nelson, D.S.: Immune aderence. In “Complement” (G.E.W. Volstenholme, J. Knight eds.) Churchill, London 1965, p 222 ffGoogle Scholar
  25. 24.
    Petz, L.D.M., Fudenberg, H.H.: Coombs-positive hemolytic anemia caused by penicillin administration. New Eng. J. Med. 274, 171 (1966)PubMedCrossRefGoogle Scholar
  26. 25.
    Pfueller, S.L., Lüscher, E.F.: The effect of immune complexes on blood platelets and heir relationship to complement activation. Immunochemistry 9, 1151 (1972)PubMedCrossRefGoogle Scholar
  27. 26.
    Pisciotta, A.V.: Immune and toxic mechanismus in drug-induced agranulocytosis. Sem. Hemat. 10, 279 (1973)Google Scholar
  28. 27.
    Raff, M.C.: T and B lymphocytes and immune responses. Nature 242, 19 (1973)PubMedCrossRefGoogle Scholar
  29. 28.
    Scott, G.L., Myles, A.B., Bacon, P.A.: Autoimmune haemolytic anaemia and mefenamic acit therapy. Brit. Med. J. 3, 534 (1968)PubMedCrossRefGoogle Scholar
  30. 29.
    Shulman, N.R.: Mechanism of blood cell damage by absorption of antigen-antibody complexes. In “Immunopathology”, III. Symposium, La Jolla, 1963, Schwabe, Basel, p 338 ffGoogle Scholar
  31. 30.
    Spath, P.: Die klinische Bedeutung immunhämatologischer Veränderungen unter Behandlung mit Penicillin und Cephalosporin. Wien. klin. Wschr. 85, Supp. 16, 1 (1973)Google Scholar
  32. 31.
    Spath, P., Garratty, G., Fudenberg, H.H.: Immunhämatologische Reaktionen bei Penicillinbehandlung. Schweiz. Med. Wschr. 103, 383 (1973)PubMedGoogle Scholar
  33. 32.
    Spath, P., Garraty, G., und Petz, L.: Studies on the immune response to penicillin and cephalotin in humans. II. Immunohematologic reactions to cephalotin administration. J. Immn. 107, 860 (1971)Google Scholar
  34. 33.
    Spielmann, W.: Ursachen und Bedeutung des positiven direkten Commbstestes unter besonderer Berücksichtigung von Alpha-Methyl-DOPA. Klin. Wschr. 47, 325 (1969)PubMedCrossRefGoogle Scholar
  35. 34.
    Swisher, S.N.: Drug reactions involving antibodies reacting with erythrocytes. In “Hematology” (W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles, eds.), New York 1972, p 506 ffGoogle Scholar
  36. 35.
    Thierfelder, S., Eulitz, M., Karl, M.L.: Immunologische Studien an einem Pyramidon-Leukozytenantikörper. Klin. Wschr. 45, 78 (1967)PubMedCrossRefGoogle Scholar
  37. 36.
    Worlledge, S.M.: Immune drug-induced hemolytic anemias. Sem. Hemat. 10, 327 (1973)Google Scholar

Copyright information

© J. F. Lehmanns Verlag München 1975

Authors and Affiliations

  • H. Huber
    • 1
  • G. Michlmayr
    • 1
  1. 1.Abteilung für Immunologie und ImmunhämatologieMedizinischen Univ. KlinikInnsbruckAustria

Personalised recommendations